Aktive Positionen von James Roger McIlroy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
EnteroBiotix Ltd.
 EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Direktor/Vorstandsmitglied | 01.03.2017 | - |
| Vorstandsvorsitzender | 01.03.2017 | - | |
| Gründer | 01.03.2017 | - | |
| Corporate Officer/Principal | 10.09.2018 | - |
Karriereverlauf von James Roger McIlroy
Statistik
International
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Health Technology |
- Börse
- Insiders
- James Roger McIlroy
- Erfahrung